ECTRIMS eLearning

Clinically isolated syndrome: natural course and diagnostic criteria
Author(s): ,
M. Seabra
Affiliations:
Neurology, Centro Hospitalar de São João; Faculty of Medicine of the University of Porto
,
M. Teixeira
Affiliations:
Faculty of Medicine of the University of Porto
,
L. Carvalho
Affiliations:
Faculty of Medicine of the University of Porto
,
L. Sequeira
Affiliations:
Neurology, CSF Laboratory
,
P. Abreu
Affiliations:
Neurology, Centro Hospitalar de São João; Faculty of Medicine of the University of Porto
,
T. Mendonça
Affiliations:
Neurology, Centro Hospitalar de São João
,
J. Reis
Affiliations:
Neurology, Centro Hospitalar de São João
,
M.J. Sá
Affiliations:
Neurology, Centro Hospitalar de São João; Energy, Environment and Health Research Unit, University Fernando Pessoa
J. Guimarães
Affiliations:
Neurology, Centro Hospitalar de São João; Faculty of Medicine of the University of Porto; Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal
ECTRIMS Learn. Seabra M. 10/10/18; 229133; EP1293
Mafalda Seabra
Mafalda Seabra
Contributions
Abstract

Abstract: EP1293

Type: Poster Sessions

Abstract Category: Clinical aspects of MS - Diagnosis and differential diagnosis

Introduction: Clinically isolated syndrome (CIS) is a first demyelinating event targeting the central nervous system. It can latter fulfil the criteria for Multiple Sclerosis (MS) but in some patients it is an isolated episode, without new clinical events or paraclinical evidence of disease.
Objectives/Aims: To analyse our population of CIS patients and the role of OCB in the 2017 revision of the McDonald criteria
Methods: We selected those patients who had ever had a diagnosis of CIS, observed in our MS clinic (N= 69), according to the 2010 McDonald criteria. Clinical and laboratorial features were analysed to compare those who converted to MS and the non-converters.
Results: From the total cohort, 71% converted to MS, at a median follow-up of 2 years (0-11 years). Those who converted to MS were tendencially younger (28 vs 33 years; p=0,066) and had an elevated level of cerebrospinal fluid (CSF) proteins (0,51 vs 0,30 g/L; p=0,072). Our analysis found no association between the presenting symptom, altered visual potentials with conversion to MS. OCB were present in 64,1% of patients who were diagnosed with MS, but also in 68,4% of those who remained CIS (p=0.745). Stratifying the results by treatment, there was also no statistical significant association between the presence of oligoclonal bands and conversion to MS.
Conclusion: The present study showed that OCB is prevalent in patients with CIS, even in those who, until now, do not fulfil the 2010 diagnostic criteria for MS. This raises questions about the early assumption of MS diagnosis, resulting in chronic treatment and a possibly lifelong stigma in patients who could never develop new lesions or have a second attack.
Disclosure: Mafalda Seabra: nothing to disclose
Mónica Teixeira: nothing to disclose
Lúcia Carvalho: nothing to disclose
Lucinda Sequeira: nothing to disclose
Pedro Abreu: nothing to disclose
Teresa Mendonça: nothing to disclose
Jorge Reis: nothing to disclose
Maria José Sá: nothing to disclose
Joana Guimarães: nothing to disclose

Abstract: EP1293

Type: Poster Sessions

Abstract Category: Clinical aspects of MS - Diagnosis and differential diagnosis

Introduction: Clinically isolated syndrome (CIS) is a first demyelinating event targeting the central nervous system. It can latter fulfil the criteria for Multiple Sclerosis (MS) but in some patients it is an isolated episode, without new clinical events or paraclinical evidence of disease.
Objectives/Aims: To analyse our population of CIS patients and the role of OCB in the 2017 revision of the McDonald criteria
Methods: We selected those patients who had ever had a diagnosis of CIS, observed in our MS clinic (N= 69), according to the 2010 McDonald criteria. Clinical and laboratorial features were analysed to compare those who converted to MS and the non-converters.
Results: From the total cohort, 71% converted to MS, at a median follow-up of 2 years (0-11 years). Those who converted to MS were tendencially younger (28 vs 33 years; p=0,066) and had an elevated level of cerebrospinal fluid (CSF) proteins (0,51 vs 0,30 g/L; p=0,072). Our analysis found no association between the presenting symptom, altered visual potentials with conversion to MS. OCB were present in 64,1% of patients who were diagnosed with MS, but also in 68,4% of those who remained CIS (p=0.745). Stratifying the results by treatment, there was also no statistical significant association between the presence of oligoclonal bands and conversion to MS.
Conclusion: The present study showed that OCB is prevalent in patients with CIS, even in those who, until now, do not fulfil the 2010 diagnostic criteria for MS. This raises questions about the early assumption of MS diagnosis, resulting in chronic treatment and a possibly lifelong stigma in patients who could never develop new lesions or have a second attack.
Disclosure: Mafalda Seabra: nothing to disclose
Mónica Teixeira: nothing to disclose
Lúcia Carvalho: nothing to disclose
Lucinda Sequeira: nothing to disclose
Pedro Abreu: nothing to disclose
Teresa Mendonça: nothing to disclose
Jorge Reis: nothing to disclose
Maria José Sá: nothing to disclose
Joana Guimarães: nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies